Skip to Main Content

SAN DIEGO — The festivities are over here at BIO 2017, but it’s been a busy week at the the drug industry’s big annual networking conference. It’s been telling, too, of what biotech leaders see as their industry’s biggest opportunities, priorities, and problems.

Here are our takeaways from four days of talking and listening to executives here:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!